And, SB02024 or SAR405 (VPS34 inhibitors) converts cold immune deserts to hot immune TMEs and reverses anti-PD-1/PD-L1 treatment resistance in melanoma and CRC tumor models (78, 143). This evidence concerns the gene CD274 and neoplasm.